Literature DB >> 16855152

Androgen and prolactin (Prl) levels in systemic sclerosis (SSc): relationship to disease severity.

Luisa Mirone1, Angela Barini, Antonella Barini.   

Abstract

Testosterone (T), sex hormone-binding globulin, (SHBG), dehydroepiandrosterone sulfate (DHEAS), and prolactin (Prl) serum levels were measured by electrochemiluminescense immunoassay (ECLIA) in 39 patients with systemic sclerosis (SSc) and compared with serum hormonal levels in control subjects matched for sex and reproductive status. A possible relationship with disease duration and disease severity was examined. Our data show an altered androgen and prolactin (Prl) status in SSc patients, in most cases related to disease duration and disease severity score. We can hypothesize that hormonal dysregulation is a consequence of the chronicity of the disease. The altered hormonal status could result in relative immunological hyperactivity contributing to enhance tissue damage and disease severity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16855152     DOI: 10.1196/annals.1351.023

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  9 in total

Review 1.  The sex bias in systemic sclerosis: on the possible mechanisms underlying the female disease preponderance.

Authors:  Fabio D'Amico; Evangelia Skarmoutsou; Maria Clorinda Mazzarino
Journal:  Clin Rev Allergy Immunol       Date:  2014-12       Impact factor: 8.667

2.  Polymorphism of the extrapituitary prolactin promoter and systemic sclerosis.

Authors:  Markéta Fojtíková; Pavlína Cejková; Radim Bečvář; Jiří Vencovský; Jana Tomasová Studýnková; Marie Cerná
Journal:  Rheumatol Int       Date:  2009-12-19       Impact factor: 2.631

3.  Prolactin alters the mechanisms of B cell tolerance induction.

Authors:  Subhrajit Saha; Juana Gonzalez; Gabriel Rosenfeld; Harold Keiser; Elena Peeva
Journal:  Arthritis Rheum       Date:  2009-06

4.  Prevalence of autoimmune disease in patients with prolactinomas and non-functioning pituitary adenomas.

Authors:  V Larouche; J A Correa; P Cassidy; C Beauregard; N Garfield; J Rivera
Journal:  Pituitary       Date:  2016-04       Impact factor: 4.107

Review 5.  Prolactin and autoimmunity.

Authors:  Luis J Jara; Gabriela Medina; Miguel A Saavedra; Olga Vera-Lastra; Carmen Navarro
Journal:  Clin Rev Allergy Immunol       Date:  2011-02       Impact factor: 8.667

6.  Estradiol levels are elevated in older men with diffuse cutaneous SSc and are associated with decreased survival.

Authors:  DeAnna Baker Frost; Bethany Wolf; Christine Peoples; Jessica Fike; Katherine Silver; Maureen Laffoon; Thomas A Medsger; Carol Feghali-Bostwick
Journal:  Arthritis Res Ther       Date:  2019-04-02       Impact factor: 5.156

7.  Exome sequencing link mutation in RGPD4 with systemic sclerosis-associated interstitial lung disease and the low level of testosterone-an exploration study.

Authors:  Na Wang; Qian Zhang; Wei Sun; Xiaoyu Yang; Hui Huang; Zuojun Xu
Journal:  Front Oncol       Date:  2022-09-08       Impact factor: 5.738

8.  Association of anti-RNA polymerase III autoantibodies and cancer in scleroderma.

Authors:  Pia Moinzadeh; Carmen Fonseca; Martin Hellmich; Ami A Shah; Cecilia Chighizola; Christopher P Denton; Voon H Ong
Journal:  Arthritis Res Ther       Date:  2014-02-14       Impact factor: 5.156

9.  Elevated plasma/serum levels of prolactin in patients with systemic sclerosis: A systematic review and meta-analysis.

Authors:  Yang Wu; Meng-Lei Li; Hua-Jing Han; Li-Jun Huang; Yong He
Journal:  Medicine (Baltimore)       Date:  2020-09-18       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.